NasdaqGM - Delayed Quote USD

Adicet Bio, Inc. (ACET)

1.3500 -0.0500 (-3.57%)
At close: June 7 at 4:00 PM EDT
1.3700 +0.02 (+1.48%)
After hours: June 7 at 6:19 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
24,990.0000
9,730.0000
17,903.0000
Operating Expense
130,125.0000
132,576.0000
97,541.0000
71,163.0000
57,094.0000
Operating Income
-130,125.0000
-132,576.0000
-72,551.0000
-61,433.0000
-39,191.0000
Net Non Operating Interest Income Expense
10,222.0000
9,953.0000
3,680.0000
-85.0000
651.0000
Other Income Expense
-19,890.0000
-20,035.0000
-919.0000
-606.0000
-953.0000
Pretax Income
-139,793.0000
-142,658.0000
-69,790.0000
-62,124.0000
-39,493.0000
Tax Provision
--
--
--
-125.0000
-2,815.0000
Net Income Common Stockholders
-139,793.0000
-142,658.0000
-69,790.0000
-61,999.0000
-36,678.0000
Diluted NI Available to Com Stockholders
-139,793.0000
-142,658.0000
-69,790.0000
-61,999.0000
-36,678.0000
Basic EPS
-2.94
-3.31
-1.70
-2.00
-5.01
Diluted EPS
-2.94
-3.31
-1.70
-2.00
-5.01
Basic Average Shares
52,071.3960
43,042.4050
41,080.2860
30,952.1520
7,319.9770
Diluted Average Shares
52,071.3960
43,042.4050
41,080.2860
30,952.1520
7,319.9770
Total Operating Income as Reported
-149,587.0000
-152,038.0000
-72,551.0000
-61,433.0000
-39,191.0000
Total Expenses
130,125.0000
132,576.0000
97,541.0000
71,163.0000
57,094.0000
Net Income from Continuing & Discontinued Operation
-139,793.0000
-142,658.0000
-69,790.0000
-61,999.0000
-36,678.0000
Normalized Income
-120,331.0000
-123,196.0000
-69,790.0000
-61,999.0000
-36,678.0000
Interest Income
10,230.0000
9,978.0000
3,760.0000
91.0000
785.0000
Interest Expense
8.0000
25.0000
80.0000
176.0000
134.0000
Net Interest Income
10,222.0000
9,953.0000
3,680.0000
-85.0000
651.0000
EBIT
-139,785.0000
-142,633.0000
-69,710.0000
-61,948.0000
-39,359.0000
EBITDA
-133,290.0000
-136,535.0000
-67,135.0000
-60,410.0000
-38,133.0000
Reconciled Depreciation
6,495.0000
6,098.0000
2,575.0000
1,538.0000
1,226.0000
Net Income from Continuing Operation Net Minority Interest
-139,793.0000
-142,658.0000
-69,790.0000
-61,999.0000
-36,678.0000
Total Unusual Items Excluding Goodwill
-19,462.0000
-19,462.0000
--
--
--
Total Unusual Items
-19,462.0000
-19,462.0000
--
--
--
Normalized EBITDA
-113,828.0000
-117,073.0000
-67,135.0000
-60,410.0000
-38,133.0000
Tax Rate for Calcs
--
--
--
0.0000
0.0001
12/31/2020 - 1/26/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TNYA Tenaya Therapeutics, Inc.
3.6400
-0.82%
 
KZR Kezar Life Sciences, Inc.
0.6847
+1.44%
 
ADIL Adial Pharmaceuticals, Inc.
1.2380
-1.75%
 
HOOK HOOKIPA Pharma Inc.
0.8190
+1.11%
 
ALGS Aligos Therapeutics, Inc.
0.5401
-6.56%
 
NKTR Nektar Therapeutics
1.2600
-9.35%
 
SPRB Spruce Biosciences, Inc.
0.6770
+0.45%
 
KRON Kronos Bio, Inc.
0.7425
+2.13%
 
ACHL Achilles Therapeutics plc
0.9020
+0.21%
 
AMLX Amylyx Pharmaceuticals, Inc.
1.7700
+0.57%